Simon Amy's most recent trade in Beam Therapeutics Inc was a trade of 55,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.95 per share. | 01 Jul 2024 | 748 | 68,805 (0%) | 0% | 23.0 | 17,167 | Common Stock |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.76 per share. | 01 Jul 2024 | 502 | 69,553 (0%) | 0% | 23.8 | 11,928 | Common Stock |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.54 per share. | 01 Apr 2024 | 16,530 | 70,060 (0%) | 0% | 30.5 | 504,851 | Common Stock |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.13 per share. | 01 Apr 2024 | 7,157 | 86,590 (0%) | 0% | 32.1 | 229,954 | Common Stock |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 27,500 | 93,747 (0%) | 0% | 0 | Common Stock | |
Beam Therapeutics Inc | Simon Amy | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.48 per share. | 10 Jul 2023 | 391 | 68,917 (0%) | 0% | 30.5 | 11,918 | Common Stock |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.77 per share. | 03 Apr 2023 | 10,493 | 70,469 (0%) | 0% | 29.8 | 312,339 | Common Stock |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.31 per share. | 03 Apr 2023 | 4,445 | 80,962 (0%) | 0% | 30.3 | 134,728 | Common Stock |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.09 per share. | 03 Apr 2023 | 1,161 | 69,308 (0%) | 0% | 29.1 | 33,777 | Common Stock |
Beam Therapeutics Inc | Amy Simon | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 20,000 | 85,129 (0%) | 0% | 0 | Common Stock |